Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Feb 7, 2025; 31(5): 101280
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101280
Table 2 Comorbidities of patients with gastrointestinal schwannomas (n = 229), n (%)
Variable
Overall
Gastrointestinal neoplasms
    Esophageal leiomyoma1 (0.4)
    Gastric stromal tumor1 (0.4)
    Gastric adenocarcinoma2 (0.9)
    Colorectal adenoma2 (0.9)
    Rectal adenocarcinoma1 (0.4)
    Adenoma of the appendix1 (0.4)
Other tumors
    Hepatocellular carcinoma4 (1.7)
    Intraductal papillary mucinous tumor of the pancreas1 (0.4)
    Adrenal cortical adenoma1 (0.4)
    Clear cell carcinoma of the kidney3 (1.3)
    Hamartoma of kidney1 (0.4)
    Non-Hodgkin’s lymphoma1 (0.4)
    Leukemia1 (0.4)
    Ovarian adenoma2 (0.9)
    Adenocarcinoma of lung2 (0.9)
    Meningioma1 (0.4)
    Adenocarcinoma of prostate1 (0.4)
    Breast cancer1 (0.4)
    Thyroid cancer1 (0.4)